PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 28 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,600 | +2.3% | 28,800 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $56,280 | +53.3% | 26,800 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $36,716 | +59.6% | 26,800 | +21.8% | 0.00% | 0.0% |
| Q3 2022 | $23,000 | -4.2% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -4.0% | 22,000 | -8.3% | 0.00% | 0.0% |
| Q1 2022 | $25,000 | +25.0% | 24,000 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $20,000 | -54.5% | 24,000 | -27.7% | 0.00% | -75.0% |
| Q3 2021 | $44,000 | – | 33,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |